A campaign of mass drug administration with artemisinin-piperaquine to antimalaria in Trobriand Islands

Preventive Medicine Reports - Tập 32 - Trang 102154 - 2023
Guoming Li1,2, Shaoqin Zheng1,2, Zhenyan Zhang2, Yanshan Hu1, Nansong Lin2, Nadia Julie1, Lei Shu2, Liwei Sun2, Hongying Zhang1,2, Yueming Yuan1,2, Yuan Liang2, Zhengjie Yu2, Wei Xie2, Ridley Mwaisiga3, Jacob Morewaya3, Qin Xu1, Jianping Song1,2,4, Changsheng Deng1,2,4
1Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People’s Republic of China
2Institute of Science and Technology Park, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People’s Republic of China
3Milne Bay Provincial Health Authority, Alotau, Milne Bay Province, Papua New Guinea
4The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People’s Republic of China

Tài liệu tham khảo

Dabira, 2022, Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia, Lancet Infect Dis, 22, 519, 10.1016/S1473-3099(21)00557-0 Deng, 2008, Therapeutic effect of Artequick for the treatment of vivax malaria in Kampuchea: An observation of 62 cases, Guangzhou University of Traditional Chinese Medicine, 25, 204 Deng, 2014, Mass Drug Administration of Artemisinin-piperaquine on High Malaria Epidemic Area, Trop Med Health, 42, 33, 10.2149/tmh.2014-S05 Deng, 2018, Large-scale Artemisinin-Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa, Clin Infect Dis, 67, 1670 Dern, 1955, The hemolytic effect of primaquine: V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity, J Lab Clin Med, 45, 30 Douglas, 2010, Artemisinin combination therapy for vivax malaria, Lancet Infect Dis, 10, 405, 10.1016/S1473-3099(10)70079-7 Epidemiology and Disease Control Division Department of Health Services, 2009. National malaria treatment protocol. Port Moresby Papua New Guinea Natl Dep Heal 2009. Fraser, 2022, Evaluating the Impact of Programmatic Mass Drug Administration for Malaria in Zambia Using Routine Incidence Data, J Infect Dis, 225, 1415, 10.1093/infdis/jiaa434 Hetzel, M.W., Saweri, O.P.M., Kuadima, J.J., Smith, I., Ura, Y., Tandrapah, A., Jamea-Maiasa, S., Siba, P.M., Pulford, J., 2018. Papua New Guinea malaria indicator survey 2016-2017: malaria prevention, infection and treatment. Kaneko, 2000, Malaria eradication on islands, The Lancet, 356, 1560, 10.1016/S0140-6736(00)03127-5 Lacerda, 2019, Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria, New England Journal of Medicine, 380, 215, 10.1056/NEJMoa1710775 Li, 2021, Mass Drug Administration With Artemisinin-Piperaquine for the Elimination of Residual Foci of Malaria in São Tomé Island, Front Med (Lausanne), 8 Li, 2022, Artemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Grande Comore island: an open-label, non-randomised controlled trial, Int J Antimicrob Agents, 10.1016/j.ijantimicag.2022.106658 Maude, 2014, The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment, Malar J, 13, 380, 10.1186/1475-2875-13-380 National Statistical Office, 2011. Papua New Guinea 2011 National Report (Census 2011). https://actnowpng.org/sites/default/files/2011%20Census%20National%20Report.pdf. Newby, 2015, Review of mass drug administration for malaria and its operational challenges, Am J Trop Med Hyg, 93, 125, 10.4269/ajtmh.14-0254 Nosten, 2007, Artemisinin-based combination treatment of falciparum malaria, Am J Trop Med Hyg, 77, 181, 10.4269/ajtmh.2007.77.181 Senn, 2013, Effectiveness of artemether/lumefantrine for the treatment of uncomplicated Plasmodium vivax and P. falciparum malaria in young children in Papua New Guinea, Clin Infect Dis, 56, 1413, 10.1093/cid/cit068 Shah, 2021, Mass drug administration for malaria, Cochrane Database of Systematic Reviews, 2021 Sinclair, D., Gogtay, N., Brand, F., Olliaro, P.L., 2011. Artemisinin‐based combination therapy for treating uncomplicated Plasmodium vivax malaria. Cochrane database of systematic reviews. Song, 2010, Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine, Malar J, 9, 57, 10.1186/1475-2875-9-57 Song, 2011, Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area, Malar J, 10, 231, 10.1186/1475-2875-10-231 Tavul, 2018, Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea, Malar J, 17, 350, 10.1186/s12936-018-2494-z Trung, 2009, A randomized, controlled trial of artemisinin-piperaquine vs dihydroartemisinin-piperaquine phosphate in treatment of falciparum malaria, Chin J Integr Med, 15, 189, 10.1007/s11655-009-0189-6 Wang, 2020, Surveillance of the Efficacy of Artemisinin-Piperaquine in the Treatment of Uncomplicated Plasmodium falciparum Malaria Among Children Under 5 Years of Age in Est-Mono District, Togo, in 2017, Front Pharmacol, 11, 784, 10.3389/fphar.2020.00784 Wikipedia, n.d. Trobriand Islands. World Health Organization Global Malaria Programme, 2015, The role of mass drug administration, mass screening and treatment, and focal screening and treatment for malaria, WHO reference number World Health Organization, 2015. Guidelines for the treatment of malaria – 3rd edition. WHO Library Cataloguing. 10.1134/S1064229310080041. World Health Organization, 2017. Mass Drug Administration for Falciparum Malaria. World Health Organization, n.d.a World Malaria Report 2015. World Health Organization, n.d.b World Malaria Report 2021.